These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32037284)

  • 21. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
    Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
    Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Recommendation to Increase Muscle (PRIMe): Study protocol for a randomized controlled pilot trial investigating the feasibility of a high protein diet to halt loss of muscle mass in patients with colorectal cancer.
    Ford KL; Sawyer MB; Trottier CF; Ghosh S; Deutz NEP; Siervo M; Porter Starr KN; Bales CW; Disi IR; Prado CM
    Clin Nutr ESPEN; 2021 Feb; 41():175-185. PubMed ID: 33487262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.
    Barret M; Antoun S; Dalban C; Malka D; Mansourbakht T; Zaanan A; Latko E; Taieb J
    Nutr Cancer; 2014; 66(4):583-9. PubMed ID: 24707897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation study.
    Smit KC; Derksen JWG; Kurk SA; Moeskops P; Koopman M; Veldhuis WB; May AM
    Clin Nutr ESPEN; 2024 Oct; 63():572-584. PubMed ID: 38997109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of body composition on chemotherapy toxicities in non-metastatic colorectal cancer patients: a systematic review.
    Choi CS; Kin K; Cao K; Hutcheon E; Lee M; Chan STF; Arafat Y; Baird PN; Yeung JMC
    ANZ J Surg; 2024 Mar; 94(3):327-334. PubMed ID: 38059530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
    Eriksson S; Nilsson JH; Strandberg Holka P; Eberhard J; Keussen I; Sturesson C
    HPB (Oxford); 2017 Apr; 19(4):331-337. PubMed ID: 28089364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle radiodensity and mortality in patients with colorectal cancer.
    Kroenke CH; Prado CM; Meyerhardt JA; Weltzien EK; Xiao J; Cespedes Feliciano EM; Caan BJ
    Cancer; 2018 Jul; 124(14):3008-3015. PubMed ID: 29797673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
    Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy.
    Cereda E; Turri A; Klersy C; Cappello S; Ferrari A; Filippi AR; Brugnatelli S; Caraccia M; Chiellino S; Borioli V; Monaco T; Stella GM; Arcaini L; Benazzo M; Grugnetti G; Pedrazzoli P; Caccialanza R
    Cancer Med; 2019 Nov; 8(16):6923-6932. PubMed ID: 31568698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
    Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
    Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.
    Gökyer A; Küçükarda A; Köstek O; Hacıoğlu MB; Sunal BS; Demircan NC; Uzunoğlu S; Solak S; İşsever K; Çiçin I; Erdoğan B
    Clin Transl Oncol; 2019 Nov; 21(11):1518-1523. PubMed ID: 30868388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: A comparison with the malnutrition screening tool.
    van der Kroft G; Bours DMJL; Janssen-Heijnen DM; van Berlo DCLH; Konsten DJLM
    Clin Nutr ESPEN; 2018 Apr; 24():114-119. PubMed ID: 29576348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent losses of skeletal muscle mass, adipose tissue and bone mineral density during bevacizumab / cytotoxic chemotherapy treatment for metastatic colorectal cancer.
    Dolly A; Lecomte T; Bouché O; Borg C; Terrebonne E; Douillard JY; Chautard R; Raoul W; Ternant D; Leger J; Bleuzen A; Dumas JF; Servais S; Baracos VE
    Clin Nutr; 2020 Nov; 39(11):3319-3330. PubMed ID: 32164981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.
    Hopkins JJ; Reif R; Bigam D; Baracos VE; Eurich DT; Sawyer MM
    World J Surg; 2019 Oct; 43(10):2518-2526. PubMed ID: 31222643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.